Dr. Christy discusses the latest research on Fluvoxamine for the treatment of COVID-19:
To enlist in a trial go to:
stopcovidtrial.wustl.edu
REFERENCES:
France Observational Study with SSRI/SNRI
Sigma 1 Receptor Agonist activity of SSRIs
CETF summary on Fluvoxamine:
Washington Post Op-Ed about Fluvoxamine:
